http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0168101-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c650353d1bbd3e8126ec847332ceb0c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eaf03c0818ab4fbfc2f0ffd284a7325 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
| filingDate | 2001-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc4f994f295a681cddb6fa6986a35f6 |
| publicationDate | 2001-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0168101-A1 |
| titleOfInvention | Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol |
| abstract | A method and composition for reducing the intestinal absorption of cholesterol in humans or animals are provided. Broadly, the methods comprise ingesting a composition (or a food product including the composition) comprising a substituted phosphatidylcholine compound, or comprising sufficient quantities of a phosphatidylcholine compound to provide from about 20-70 % by weight of C18 or higher alkyl groups. Preferred substituted phosphatidylcholine compounds include monoether phosphatidylcholines, diether phosphatidylcholines (wherein the alkyl group bonded to the second carbon atom of the glycerol moiety is a C17 or higher alkyl group), or ester or diester phosphatidylcholines. Preferred C18 or higher alkyl group include C18-C22 alkyl groups, preferably bonded to the second carbon atom of the glycerol moiety of the phosphatidylcholine compound. |
| priorityDate | 2000-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.